US Patent 8058427 Coumarin compounds and their use for treating cancer
Patent 8058427 was granted and assigned to National Health Research Institutes on November, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+49 characters)
Article
Patent abstract
Coumarin compounds of formula (I):
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Ching-Chuan Kuo0
Hsing-Pang Hsieh0
Jang-Yang Chang0
Yu-Sheng Chao0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08058427 Coumarin compounds and their use for treating cancer US Patent 8058427 Coumarin compounds and their use for treating cancer
Infobox
Patent Number
08058427
Patent Number
8058427
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08058427 Coumarin compounds and their use for treating cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08058427
Date of patent
November 15, 2011
Patent application number
12481783
Date Filed
June 10, 2009
Patent primary examiner
Find more entities like US Patent 8058427 Coumarin compounds and their use for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
